This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Silver Standard Resources Inc (SSRI)

NASDAQ: Basic Materials

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -126.39M -225.00M 54.83M 80.13M
Operating Gains/Losses -2.92M -74.57M -54.61M -107.77M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 14.56M -2.92M -38.27M 19.83M
(Increase) Decrease in Inventories 3.38M 1.55M -5.81M -50.07M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -1.77M 15.79M 29.05M 11.73M
(Decrease) Increase In Other Current Liabilities 7.20M 0.00 -21.79M 16.86M
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 132.47M 262.43M 11.91M 14.59M
Net Cash From Continuing Operations 68.83M 19.47M 5.41M 5.68M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 68.83M 19.47M 5.41M 5.68M
Sale of Property, Plant & Equipment 17.50M 15.00M 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 39.25M 0.00 0.00 0.00
Purchases of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Acquisitions 0.00 0.00 71.04M 112.38M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -63.87M -36.37M 17.97M 24.03M
Cash Provided by Financing Activities
Net Cash From Investing Activities -298.70M -76.58M 31.86M 70.98M
Issuance of Debt 5.92M 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 77.00K 618.00K 20.09M
Repayment of Long-Term Debt 0.00 -138.00M 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 256.08M 0.00 0.00
Net Cash From Financing Activities 5.92M 118.16M 618.00K 20.09M
Effect of Exchange Rate Changes -7.07M -12.34M 0.00 0.00
Net Change in Cash & Cash Equivalents -231.01M 48.71M 37.89M 96.74M
SSRI News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

SSRI Silver Standard Resources Inc

Chart of SSRI

Analysts Ratings for SSRI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SSRI ANALYST REPORT

SSRI Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs